Category: Johnson & JohnsonSyndicate content

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Johnson & Johnson launches $5B buyback

July 22, 2014 by Arezu Sarvestani

Healthcare giant Johnson & Johnson plans to repurchase up to $5 billion of its own shares over an indefinite amount of time.

Johnson & Johnson buys back $5B shares

Johnson & Johnson (NYSE:JNJ) last night announced that its board of directors approved a $5 billion open-ended repurchase program for shares of the company's common stock.

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

Johnson & Johnson CEO Alex Gorsky says the healthcare giant is eyeing acquisitions to bolster its 'subscale' cardiovascular business and, possibly, other aspects of its medical device business.

YYmeta

The world's largest medical device operation is eyeing acquisitions to bolster its "subscale" cardiovascular business, particularly its electrophysiology business, Johnson & Johnson (NYSE:JNJ) chairman & CEO Alex Gorsky told analysts yesterday.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Pharma delivers another beat & raise quarter for Johnson & Johnson

July 15, 2014 by Brad Perriello

Johnson & Johnson's pharmaceuticals division helps buoy the healthcare giant to another beat & raise quarter, but its medical device division again fails to meet expectations.

Pharma delivers another beat & raise quarter for Johnson & Johnson

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Guidant loses bid to drop breach-of-contract in JNJ lawsuit | Medtech legal news for the week of July 14, 2014

July 14, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Guidant can't slip breach-of-contract charges in Johnson & Johnson suit; Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico; Appeals court upholds Retractable Technologies win over Becton Dickinson; Board suspends ex-PricewaterhouseCoopers accountant over ArthroCare scandal; Covidien's Nellcor and CAS Medical settle dispute for $275k

Guidant can't slip breach-of-contract charges in Johnson & Johnson suit

July 8, 2014 by Brad Perriello

UPDATE: FDA panel inconclusive on power morcellators

July 14, 2014 by Ingrid Mezo

An FDA panel convened last week to evaluate the use of laparoscopic power morcellators in removing uterine fibroids, implicated in spreading cancer, failed to reach a consensus on their safety despite outraged testimony from physicians and attendees at the hearing.

UPDATE: FDA panel inconclusive on power morcellators

An FDA panel convened last week to consider the use of a controversial procedure to remove uterine fibroids failed to come to a clear decision on the cancer risk from laparoscopic power morcellators, despite outraged testimony from dozens of attendees.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien names Bill Burke as CFO to lead Medtronic merger | The week in medtech M&A

July 9, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale

Covidien taps integration chief to navigate Medtronic merger

July 3, 2014 by Arezu Sarvestani

Covidien taps integration chief to navigate Medtronic merger
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp